ProfileGDS5822 / ILMN_2627400
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 6% 26% 12% 48% 41% 29% 5% 20% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 18.56
GSM1276600PDAC Late Ablation Control 216.426
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 19.312
GSM1276603PDAC Late Ablation 222.248
GSM1276604PDAC Late Ablation 319.841
GSM1303940PDAC Late Ablation_anti-CTLA4 115.329
GSM1303941PDAC Late Ablation_anti-CTLA4 24.65
GSM1303942PDAC Late Ablation_anti-CTLA4 310.620